Stocktoria
VIVOS INC RDGL
OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2001-08-08
VIVOS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $68,379 | $27,995 | $19,500 | $36,499 | $14,887 | $7,000 | $9,500 | — | $4,054 | — |
| Gross profit | -$59,755 | -$2,984 | -$6,036 | $7,720 | $2,887 | $1,392 | $3,472 | — | — | — |
| R&D expense | $352,232 | $324,629 | $732,698 | $343,802 | $286,848 | $84,668 | $67,584 | $104,208 | $203,037 | $328,026 |
| Operating income | -$3.2M | -$2.6M | -$2.8M | -$2.5M | -$2.5M | -$672,521 | -$1.3M | -$2.5M | -$2.6M | -$4.4M |
| Interest expense | — | — | — | — | $25,375 | $287,471 | $261,374 | $5.6M | $3.9M | $6.3M |
| Income tax | — | — | — | — | $0 | $0 | — | — | — | $0 |
| Net income | -$3.1M | -$2.9M | -$2.9M | -$2.5M | -$2.5M | -$956,992 | -$1.6M | -$7.7M | -$6.4M | -$9.9M |
| EPS (diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | — | — | — | — | — | — |
| Operating cash flow | -$2.1M | -$2.5M | $2.5M | $2.5M | $2.5M | $2.0M | $2.3M | $2.3M | $1.5M | -$1.9M |
| Free cash flow | -$2.2M | — | — | — | — | — | — | — | — | — |
| Cash & equivalents | — | $2.2M | $1.6M | $1.7M | $1.6M | $903,704 | $20,381 | $5,494 | $8,317 | $27,889 |
| Inventory | $57,257 | — | — | — | — | — | — | — | $8,475 | $0 |
| Total assets | $1.9M | $2.2M | $1.6M | $1.7M | $1.6M | $937,539 | $43,873 | $16,486 | $15,697 | $41,996 |
| Total liabilities | $206,743 | $86,209 | $245,004 | $81,692 | $166,915 | $905,505 | $1.5M | $958,660 | $4.3M | $3.1M |
| Shareholders' equity | $1.7M | $2.1M | $1.4M | $1.7M | $1.5M | $32,034 | -$1.5M | -$942,174 | -$4.3M | -$3.0M |
Growth · year-over-year · Revenue CAGR 49.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +144.3% | +43.6% | -46.6% | +145.2% | +112.7% | -26.3% | — | — | — | — |
| Net income growth | — | — | — | — | — | — | — | — | — | -258.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.